The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis
Open accessAbstract
BACKGROUND: Butyrate oxidation within the colonocyte is selectively inhibited by hydrogen sulphide, reproducing the metabolic lesion observed in active ulcerative colitis. AIMS: To study generation of hydrogen sulphide by sulphate reducing bacteria (SRB) and the effects of 5-aminosalicylic acid (5-ASA) in patients with ulcerative colitis in order to identify a role of this noxious agent in pathogenesis. PATIENTS: Fresh faeces were obtained from 37 patients with ulcerative colitis (23 with active disease) and 16 healthy controls. METHODS: SRB were enumerated from fresh faecal slurries and measurements made of sulphate reducing activity, and sulphate and hydrogen sulphide concentrations. The effect of 5-ASA on hydrogen sulphide production was studied in vitro. RESULTS: All controls and patients with active ulcerative colitis carried SRB and total viable counts were significantly related to the clinical severity grade. SRB were of two distinct types: rapidly growing strains (desulfovibrios) which showed high sulphate reduction rates, present in 30% of patients with ulcerative colitis and 44% of controls; and slow growing strains which had little activity. In vitro, 5-ASA inhibited sulphide production in a dose dependent manner; in patients with ulcerative colitis not on these drugs faecal sulphide was significantly higher than in controls (0.55 versus 0.25 mM, p=0.027). CONCLUSIONS: Counts and carriage rates of SRB in faeces of patients with ulcerative colitis are not significantly different from those in controls. SRB metabolism is not uniform between strains and alternative sources of hydrogen sulphide production exist in the colonic lumen which may be similarly inhibited by 5-ASA. The evidence for hydrogen sulphide as a metabolic toxin in ulcerative colitis remains circumstantial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man.
Roediger, W. E. (1980) · Gut · doi:10.1136/gut.21.9.793 · Cited by 1,310
Utilization of Nutrients by Isolated Epithelial Cells of the Rat Colon
Roediger, W. E. W. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80339-9 · Cited by 1,191
The sulphate-reducing bacteria
Postgate, J. R. (1979) · Medical Entomology and Zoology · Cited by 1,096
The Sulphate-Reducing Bacteria
Hamilton, W. A. (1984) · British Corrosion Journal · doi:10.1179/000705984798273407 · Cited by 832
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
Khan, A. K. A., Piris, J., & Truelove, S. C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90831-5 · Cited by 814
J⊘rgensen, B. B. (1978) · Geomicrobiology Journal · doi:10.1080/01490457809377721 · Cited by 721
THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE?
Roediger, W. E. W. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91934-0 · Cited by 719
Cited by
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
Wang, R. (2012) · Physiological Reviews · doi:10.1152/physrev.00017.2011 · Cited by 1,939
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160
A review of the volatiles from the healthy human body
de Lacy Costello, B., Amann, A., Al-Kateb, H., Flynn, C., Filipiak, W., Khalid, T., Osborne, D., & Ratcliffe, N. M. (2014) · Journal of Breath Research · doi:10.1088/1752-7155/8/1/014001 · Cited by 1,042
“Hydrogen sulfide and methanethiol can be damaging to the large intestinal epithelium and are also generated from sulphur-containing substances in the diet [198].”
BackgroundThe gut microbiota and inflammatory bowel disease
Matsuoka, K., & Kanai, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0454-4 · Cited by 804
Nutrients, foods, and colorectal cancer prevention
Song, M., Garrett, W. S., & Chan, A. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.035 · Cited by 700
Relevance of protein fermentation to gut health
Windey, K., De Preter, V., & Verbeke, K. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100542 · Cited by 692
Microbial pathways in colonic sulfur metabolism and links with health and disease
Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H., & Gaskins, H. R. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00448 · Cited by 544
“Specifically, 5-aminosalicylic acid (5- ASA), an anti-inflammatory medication commonly prescribed for UC, also inhibits SRB growth and production of H2S (Pitcher et al., 2000; Edmond et al., 2003).”
BackgroundResultJowett, S. L., Seal, C. J., Pearce, M. S., Phillips, E., Gregory, W., Barton, J. R., & Welfare, M. R. (2004) · Gut · doi:10.1136/gut.2003.024828 · Cited by 462
Gut Microbiota and Inflammation
Hakansson, A., & Molin, G. (2011) · Nutrients · doi:10.3390/nu3060637 · Cited by 455
Blachier, F., Mariotti, F., Huneau, J. F., & Tomé, D. (2007) · Amino Acids · doi:10.1007/s00726-006-0477-9 · Cited by 452
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
Garner, C. E., Smith, S., de Lacy Costello, B., White, P., Spencer, R., Probert, C. S. J., & Ratcliffem, N. M. (2007) · The FASEB Journal · doi:10.1096/fj.06-6927com · Cited by 439
Metabolic niche of a prominent sulfate-reducing human gut bacterium
Rey, F. E., Gonzalez, M. D., Cheng, J., Wu, M., Ahern, P. P., & Gordon, J. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312524110 · Cited by 422
Sulfide, the first inorganic substrate for human cells
Goubern, M., Andriamihaja, M., Nübel, T., Blachier, F., & Bouillaud, F. (2007) · The FASEB Journal · doi:10.1096/fj.06-7407com · Cited by 422
Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases
Loubinoux, J., Bronowicki, J., Pereira, I. A. C., Mougenel, J.-L., & Faou, A. L. (2002) · FEMS Microbiology Ecology · doi:10.1016/s0168-6496(02)00201-5 · Cited by 388
Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention
Song, M., & Chan, A. T. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.012 · Cited by 355
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases
Lewis, J. D., & Abreu, M. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.019 · Cited by 375
Kastl, A. J., Terry, N. A., Wu, G. D., & Albenberg, L. G. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.07.006 · Cited by 358
Fukui, H. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000447252 · Cited by 355
Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls
Kleessen, B., Kroesen, A. J., Buhr, H. J., & Blaut, M. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320378220 · Cited by 351
Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
Zhang, M., Sun, K., Wu, Y., Yang, Y., Tso, P., & Wu, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00942 · Cited by 347
Towards microbial fermentation metabolites as markers for health benefits of prebiotics
Verbeke, K. A., Boobis, A. R., Chiodini, A., Edwards, C. A., Franck, A., Kleerebezem, M., Nauta, A., Raes, J., van Tol, E. A. F., & Tuohy, K. M. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000037 · Cited by 343
Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota
Xu, J., Chen, H., & Li, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21431 · Cited by 340
Desulfovibrio Bacterial Species Are Increased in Ulcerative Colitis
Rowan, F., Docherty, N. G., Murphy, M., Murphy, B., Coffey, J. C., & O‘Connell, P. R. (2010) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181f1e620 · Cited by 333
Taurocholic acid metabolism by gut microbes and colon cancer
Ridlon, J. M., Wolf, P. G., & Gaskins, H. R. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1150414 · Cited by 327
When anaerobes encounter oxygen: mechanisms of oxygen toxicity, tolerance and defence
Lu, Z., & Imlay, J. A. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00583-y · Cited by 318
Where in the world do bacteria experience oxidative stress?
Imlay, J. A. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14445 · Cited by 313
Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats
Wallace, J. L., Vong, L., McKnight, W., Dicay, M., & Martin, G. R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.012 · Cited by 308
Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation
Daeffler, K. N., Galley, J. D., Sheth, R. U., Ortiz‐Velez, L. C., Bibb, C. O., Shroyer, N. F., Britton, R. A., & Tabor, J. J. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167416 · Cited by 301
Intestinal microbiota in inflammatory bowel disease: Friend of foe?
Fava, F. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.557 · Cited by 300
Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
Ijssennagger, N., van der Meer, R., & van Mil, S. W. C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.002 · Cited by 296
Contributions of the microbial hydrogen economy to colonic homeostasis
Carbonero, F., Benefiel, A. C., & Gaskins, H. R. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.85 · Cited by 293
Drabińska, N., Flynn, C., Ratcliffe, N., Belluomo, I., Myridakis, A., Gould, O., Fois, M., Smart, A., Devine, T., & Costello, B. D. L. (2021) · Journal of Breath Research · doi:10.1088/1752-7163/abf1d0 · Cited by 288
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Hydrogen Sulfide Induces Direct Radical-Associated DNA Damage
Attene-Ramos, M. S., Wagner, E. D., Gaskins, H. R., & Plewa, M. J. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0439 · Cited by 276
A metagenomic study of the gut microbiome in Behcet’s disease
Ye, Z., Zhang, N., Wu, C., Zhang, X., Wang, Q., Huang, X., Du, L., Cao, Q., Tang, J., Zhou, C., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0520-6 · Cited by 272
Gastrointestinal biofilms in health and disease
Motta, J.-P., Wallace, J. L., Buret, A. G., Deraison, C., & Vergnolle, N. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00397-y · Cited by 270
Microbiome, inflammation and colorectal cancer
Chen, J., Pitmon, E., & Wang, K. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.006 · Cited by 265
Hydrogen sulfide in physiology and diseases of the digestive tract
Singh, S., & Lin, H. (2015) · Microorganisms · doi:10.3390/microorganisms3040866 · Cited by 260
Teague, B., Asiedu, S., & Moore, P. K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704858 · Cited by 258
Desulfovibrio in the Gut: The Enemy within?
Singh, S. B., Carroll-Portillo, A., & Lin, H. C. (2023) · Microorganisms · doi:10.3390/microorganisms11071772 · Cited by 256
H2S and its role in redox signaling
Kabil, O., Motl, N., & Banerjee, R. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.01.002 · Cited by 240
Race-dependent association of sulfidogenic bacteria with colorectal cancer
Yazici, C., Wolf, P. G., Kim, H., Cross, T.-W. L., Vermillion, K., Carroll, T., Augustus, G. J., Mutlu, E., Tussing-Humphreys, L., Braunschweig, C., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313321 · Cited by 215
Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis
Rowan, F. E., Docherty, N. G., Coffey, J. C., & O'Connell, P. R. (2009) · British Journal of Surgery · doi:10.1002/bjs.6454 · Cited by 201
Emerging roles of hydrogen sulfide in inflammatory and neoplastic colonic diseases
Guo, F.-F., Yu, T.-C., Hong, J., & Fang, J.-Y. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00156 · Cited by 146
“An epidemiologic study revealed that patients suffering from UC had either excessive SRB colonization or excessive H2S in their feces (Pitcher et al., 2000; Rowan et al., 2009).”
BackgroundMicrobial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
Hatamnejad, M. R., Baradaran Ghavami, S., Shirvani, M., Asghari Ahmadabad, M., Shahrokh, S., Farmani, M., Sherkat, G., Asadzadeh Aghdaei, H., & Zali, M. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980189 · Cited by 28
Antibiotic-Resistant Desulfovibrio Produces H2S from Supplements for Animal Farming
Karnachuk, O. V., Beletsky, A. V., Rakitin, A. L., Ikkert, O. P., Avakyan, M. R., Zyusman, V. S., Napilov, A., Mardanov, A. V., & Ravin, N. V. (2023) · Microorganisms · doi:10.3390/microorganisms11040838 · Cited by 13
“Possible associations of SRB with pathologies, including ulcerative colitis [3,9,10], inflammatory bowel disease [11], colorectal cancer [12,13], bacteremia [4,14–17], brain abscess [18] and renal infection [19], are discussed in the scientific literature.”
Background
Metadata
- Authors
- Pitcher, M. C. L.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2000-01-01
- Volume
- 46
- Issue
- 1
- Pages
- 64-72
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2129844770
- Cited by
- 295
- References
- 66
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.